期刊文献+

尿毒症继发性甲旁亢甲状旁腺切除术临床观察 被引量:10

Clinical observation of parathyroidectomy in uremic patients with secondary hyperparathyroidism
下载PDF
导出
摘要 目的探讨尿毒症继发性甲状旁腺功能亢进症(继发性甲旁亢)的临床特征、发病机制及甲状旁腺切除术的治疗意义。方法回顾性总结3例尿毒症继发性甲旁亢患者甲状旁腺切除术前、术后的临床表现、实验室及影像学检查、病理活检结果,结合文献分析其发病机制及手术的治疗意义。结果3例患者存在不同程度的肌肉骨骼皮肤症状、转移性钙化,血清Ca、P、PTH升高,X线下骨病变,彩超及病理活检甲状旁腺结节状增生或腺瘤形成,术后明显好转。结论尿毒症继发性甲旁亢引起多系统损害,甲状旁腺切除术是治疗药物无效甲旁亢的有效方法。 Objective To investigate the clinical feature,pathogenesis of secondary hyper-parathyroidism(SHPF) and parathyroidectomy in uremic patients. Methods Three patients undergone parathyroidectomy due to uremic SHPT were reported retrospectively:preoperative and postoperative clinical manifestations, results of lab testing,imaging and pathologic biopsy. To discuss the pathogenesis and surgical treatment with literature. Results Three patients had different levels of musculoskeletal, skin malaise and ectopic calcification. Serum calcium,phosphorus and PTH concentration increased. Different skeletal disorders were seen with X-ray. Nodular hyperplasia or adenoma of parathyroid were found in color uhrasonograph and pathologic biopsy. Most of these lesions improved after surgery. Conclusion Uremic SHPT may cause multiple-system lesions. Parathyroidectomy should be chosen when medical treatment is invalid.
出处 《中国实用医药》 2009年第29期17-19,共3页 China Practical Medicine
关键词 尿毒症 继发性甲旁亢 甲状旁腺切除术 Uremia Secondary Hyperparathyroidism Parathyroideetomy
  • 相关文献

参考文献16

  • 1De Boer IH, Gorodetskaya I, Young B, et al. The Severity of Secondary Hyperparathyroidism in Chronic Renal Insufficiency is GFR-Dependent,Race-Dependent,and Associated with Cardiovascular Disease. J Am See Nephrol,2002,13 ( 11 ) :2762-2769.
  • 2Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol, 2005,288 ( 2 ) : 253-264.
  • 3Tokumoto M, Taniguchi M, Matsuo D, et al. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism:vitamin D receptor,calcium sensing receptor,and cell cycle regulating factors. Ther Apher Dial,2005,9( 1 ) :27-34.
  • 4Hruska KA, Steven L, Teitelbaum. Renal osteodystrophy. N Engl J Med, 1995,333 (3) : 166-174.
  • 5Raggi P, Boulay A, Chasan-Taber S, et al, Cardiac calcification in adult hemodialysis patients:A link between ESRD and cardiovascular disease. J Am Coll Cardiol,2002,39(4) :695-701.
  • 6欧三桃,赵安菊,黄颂敏.继发性甲旁亢对慢性肾衰竭患者的影响及治疗进展[J].国际泌尿系统杂志,2006,26(6):831-834. 被引量:9
  • 7Drueke TB, Eckardt KU. Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients. Nephrol Dial Transplant,2002,17 (5) :28-31.
  • 8施俊义.继发性甲状旁腺功能亢进的诊断与治疗[J].中国实用外科杂志,2008,28(3):185-186. 被引量:29
  • 9EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism:the Dialysis Outcomes and Practice Patterns Study. Kidney Int ,2005,67 ( 3 ) : 1179-1187.
  • 10<活性维生素D的合理应用>专家协作组.活性维生素D在慢性肾脏病继发性甲旁亢中合理应用的专家共识(修订版)[J].中华肾脏病杂志,2005,21(11):698-699. 被引量:97

二级参考文献23

  • 1Silver J,Levi R.Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.Kidney Int,2005,(suppl95):S8-12.
  • 2Sanchez CP,Goodman WG,Salusky IB.Prevention of renal osteodystrophy in predialysis patients.Am J Med Sci,1999,317:398-404.
  • 3Moallem E,Kilav R,Silver J,Naveh-Many T.RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate.J Biol Chem,1998,273:5253-9.
  • 4Ghazali A,Fardellone P,Pruna A,et al.Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? Kidney Int,1999,55:2169-7.
  • 5Spasovski GB,Bervoets AR,Behets GJ,et al.Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.Nephrol Dial Transplant,2003,18(6):1159-566.
  • 6Atsumi K,Kushida K,Yamazaki K et al.Risk factors for vertebral fractures in renal osteodystrophy.Am J Kidney Dis,1999,33:287-93.
  • 7Pecovnik Balon B,Puklavec L,Hojs R.Comparison of the intact PTH test with the total PTH test in hemodialyzed patients.Acta Med Croatica,2003,57(1):69-70.
  • 8Goodman WG,Goldin J,Kuizon BD,et al.Coronary-artery calcification in young adults with end-stage renal disease who are undergo ing dialysis.N Engl J Med,2000,342:1478-83.
  • 9Bleyer A J,Burkart J,Piazza M,et al.Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD.Am J Kidney Dis,2005,46(3):464-9.
  • 10Ganesh SK,Stack AG,Lewin NW et al.Association of elevated serum PO(4),Ca×PO(4)product,and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients.J Am Soc Nephrol,2001,12:2131-8.

共引文献132

同被引文献57

  • 1唐万欣,付平,杨宁,周莉,黄颂敏,许国章.高通量透析与低通量透析对尿毒症皮肤瘙痒疗效的比较研究[J].临床荟萃,2005,20(17):964-967. 被引量:8
  • 2张成果,沈俊智,王翠合,王凤莲,张俊领.不同血液净化方法对尿毒症皮肤瘙痒的治疗效果[J].中国血液净化,2007,6(3):171-173. 被引量:19
  • 3何雪梅,毛永辉,吴华.尿毒症皮肤瘙痒的发病机制及其研究进展[J].国际移植与血液净化杂志,2007,5(4):21-25. 被引量:14
  • 4王质刚.血液净化学[M].3 版.北京:科学技术出版社,2010:857-867.
  • 5朱萍,汪关煜,俞育飞,王素娥,钱莹.尿毒症瘙痒临床研究初探[J].肾脏病与透析肾移植杂志,1997,6(1):39-42. 被引量:49
  • 6Drueke TB,Eckardt KU. Role of secondary hyperparathyroidism inerythropoietin resistance of chronic renal failure patients Nephrol Di-al Transplant,2002,17(5) :28-31.
  • 7Rayes N, Seehofer D,Schindler R,et al, Long-term results of sub-total vs total parathyroidectomy without autotrans -plantation in kid-ney transplant recipients. Arch Sui^, 2008,143 : 756-761.
  • 8Mathur VS, Lindberg J, Germain M, et al. A longitudinal study of uremic pruritus in hemodialysis patients[J]. Clin J Am Soc Nephrol, 2010,5(8) :1410 -1419.
  • 9Mettang T, Fritz P,Weber J, et al. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells[J]. Clin Nephrol, 1990,34(3) : 136-141.
  • 10Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and anemia in uremic subjects :a combined therapeutic approach[J]. J Am Soc Nephrol,2004,15 Suppl 1 :S21-24.

引证文献10

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部